Developmental anomaly of metabolic origin
MONDO:0015327383 clinical trials for this condition and its sub-types, 0 tagged with Developmental anomaly of metabolic origin itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Developmental anomaly of metabolic origin
-
Inborn mitochondrial metabolism disorder 59 trials · 127 incl. sub-types
14 sub-types
- Mitochondrial oxidative phosphorylation disorder 3 trials · 58 incl. sub-types Sub-types →
- Inborn mitochondrial myopathy 18 trials · 45 incl. sub-types Sub-types →
- Pyruvate dehydrogenase deficiency 2 trials · 4 incl. sub-types Sub-types →
- Histiocytoid cardiomyopathy 3 trials Sub-types →
- Fumaric aciduria 2 trials
- OPA1-related optic atrophy with or without extraocular features 1 trial Sub-types →
- Inherited lipoic acid biosynthesis defect 0 trials · 1 incl. sub-types Sub-types →
- Multiple acyl-CoA dehydrogenase deficiency 1 trial Sub-types →
- 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 0 trials
- HSD10 mitochondrial disease 0 trials Sub-types →
- Hypotonia-cystinuria syndrome 0 trials Sub-types →
- Mitochondrial membrane transport disorder 0 trials Sub-types →
- Mitochondrial pyruvate carrier deficiency 0 trials
- Oxoglutaricaciduria 0 trials
-
Fabry disease 64 trials
-
Mucopolysaccharidosis 14 trials · 61 incl. sub-types
8 sub-types
- Mucopolysaccharidosis type 2 24 trials Sub-types →
- Mucopolysaccharidosis type 3 7 trials · 18 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 1 11 trials · 16 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 4 2 trials · 10 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 6 8 trials Sub-types →
- Mucopolysaccharidosis type 7 8 trials
- Mucopolysaccharidosis type 9 1 trial
- Mucopolysaccharidosis, type 10 0 trials
-
Sterol biosynthesis disorder 0 trials · 45 incl. sub-types
7 sub-types
- CHILD syndrome 37 trials
- Cholesterol biosynthetic process disease 2 trials · 6 incl. sub-types Sub-types →
- Mevalonate kinase deficiency 3 trials · 4 incl. sub-types Sub-types →
- Greenberg dysplasia 2 trials
- X-linked chondrodysplasia punctata 1 trial Sub-types →
- MEND syndrome 0 trials
- Microcephaly-congenital cataract-psoriasiform dermatitis syndrome 0 trials
-
Fanconi anemia 29 trials · 42 incl. sub-types
22 sub-types
- Fanconi anemia complementation group D1 6 trials
- Fanconi anemia complementation group A 4 trials
- Fanconi anemia complementation group E 4 trials
- Fanconi anemia complementation group N 2 trials
- Fanconi anemia, complementation group S 2 trials
- Fanconi anemia complementation group B 0 trials
- Fanconi anemia complementation group C 0 trials
- Fanconi anemia complementation group D2 0 trials
- Fanconi anemia complementation group F 0 trials
- Fanconi anemia complementation group G 0 trials
- Fanconi anemia complementation group I 0 trials
- Fanconi anemia complementation group J 0 trials
- Fanconi anemia complementation group L 0 trials
- Fanconi anemia complementation group O 0 trials
- Fanconi anemia complementation group P 0 trials
- Fanconi anemia complementation group Q 0 trials
- Fanconi anemia complementation group R 0 trials
- Fanconi anemia complementation group T 0 trials
- Fanconi anemia complementation group U 0 trials
- Fanconi anemia complementation group V 0 trials
- Fanconi anemia, complementation group W 0 trials
- Fanconi anemia, complementation group 10 0 trials
-
Hypophosphatasia 13 trials
8 sub-types
- ALPL-related autosomal dominant hypophosphatasia 0 trials Sub-types →
- ALPL-related autosomal recessive hypophosphatasia 0 trials Sub-types →
- Adult hypophosphatasia 0 trials
- Childhood hypophosphatasia 0 trials
- Infantile hypophosphatasia 0 trials
- Moderate hypophosphatasia 0 trials
- Odontohypophosphatasia 0 trials
- Prenatal benign hypophosphatasia 0 trials
-
Oligosaccharidosis 0 trials · 11 incl. sub-types
7 sub-types
- Alpha-mannosidosis 5 trials Sub-types →
- Aspartylglucosaminuria 4 trials
- Fucosidosis 2 trials
- Galactosialidosis 2 trials
- Sialidosis 1 trial · 2 incl. sub-types Sub-types →
- Alpha-N-acetylgalactosaminidase deficiency 0 trials Sub-types →
- Beta-mannosidosis 0 trials
-
Pseudohypoparathyroidism 8 trials · 9 incl. sub-types
5 sub-types
- Pseudohypoparathyroidism type 1A 7 trials
- Pseudopseudohypoparathyroidism 2 trials
- Pseudohypoparathyroidism type 1B 0 trials
- Pseudohypoparathyroidism type 1C 0 trials
- Pseudohypoparathyroidism type 2 0 trials
-
Zellweger spectrum disorders 6 trials · 7 incl. sub-types
15 sub-types
- Peroxisome biogenesis disorder due to PEX1 defect 0 trials · 1 incl. sub-types Sub-types →
- Peroxisome biogenesis disorder 9B 0 trials
- Peroxisome biogenesis disorder due to PEX10 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX11B defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX12 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX13 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX14 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX16 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX19 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX2 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX26 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX3 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX5 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX6 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder, complementation group 2 0 trials
-
Cockayne syndrome 6 trials
4 sub-types
- Cockayne spectrum with or without cerebrooculofacioskeletal syndrome 0 trials
- Cockayne syndrome type 1 0 trials
- Cockayne syndrome type 2 0 trials
- Cockayne syndrome type 3 0 trials
-
Creatine transporter deficiency 6 trials
-
Mucolipidosis 4 trials · 5 incl. sub-types
2 sub-types
- Familial mucolipidosis 0 trials · 5 incl. sub-types Sub-types →
- GNPTAB-mucolipidosis 0 trials Sub-types →
-
Classic homocystinuria 4 trials
-
Mucosulfatidosis 4 trials
-
AICA-ribosiduria 1 trial
-
Nijmegen breakage syndrome 1 trial
-
2 sub-types
-
Occipital horn syndrome 1 trial
-
Encephalopathy due to sulfite oxidase deficiency 0 trials · 1 incl. sub-types
2 sub-types
- Sulfite oxidase deficiency due to molybdenum cofactor deficiency 0 trials · 1 incl. sub-types Sub-types →
- Isolated sulfite oxidase deficiency 0 trials
-
ALDH18A1-related de Barsy syndrome 0 trials
-
Al-Gazali syndrome 0 trials
-
CADDS 0 trials
-
CHIME syndrome 0 trials
-
2 sub-types
-
3 sub-types
-
Larsen-like syndrome, B3GAT3 type 0 trials
-
Neu-Laxova syndrome 0 trials
3 sub-types
- Neu-Laxova syndrome 1 0 trials
- Neu-Laxova syndrome 2 0 trials
- Neu-laxova syndrome due to 3-phosphoserine phosphatase deficiency 0 trials
-
Peters plus syndrome 0 trials
-
SHORT syndrome 0 trials
-
SLC39A8-CDG 0 trials
-
Wiedemann-Rautenstrauch syndrome 0 trials
-
4 sub-types
-
Cutis laxa, autosomal dominant 3 0 trials
-
6 sub-types
- Hyperphosphatasia with intellectual disability syndrome 1 0 trials
- Hyperphosphatasia with intellectual disability syndrome 2 0 trials
- Hyperphosphatasia with intellectual disability syndrome 3 0 trials
- Hyperphosphatasia with intellectual disability syndrome 4 0 trials
- Hyperphosphatasia with intellectual disability syndrome 5 0 trials
- Hyperphosphatasia with intellectual disability syndrome 6 0 trials
-
Mandibuloacral dysplasia 0 trials
2 sub-types
-
Mucopolysaccharidosis-plus syndrome 0 trials
-
Pontocerebellar hypoplasia type 1 0 trials
3 sub-types
- Pontocerebellar hypoplasia type 1A 0 trials
- Pontocerebellar hypoplasia type 1B 0 trials
- Pontocerebellar hypoplasia, type 1C 0 trials
-
Transketolase deficiency 0 trials
Most studied deeper sub-types
-
Can a One-Time gene therapy fix fabry disease for years?
Cure Stopped earlyThis study follows people with Fabry disease who have already received FLT190, an experimental gene therapy that delivers a working copy of the GLA gene. The goal is to see how safe the treatment is over the long term and whether its effects last. Researchers will track participa…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Can a single gene infusion rewrite the story of fabry disease?
Cure Stopped earlyThis trial is testing a gene therapy called FLT190 in adult men with classic Fabry disease, a genetic condition that causes harmful fat buildup in cells. The therapy uses a modified virus to deliver a working copy of the faulty gene, potentially enabling the body to produce the m…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Gene therapy aims to fix bone marrow failure in fanconi anemia
Disease control Stopped earlyThis trial tests a gene therapy for Fanconi anemia, a rare genetic disorder that causes bone marrow failure and increases cancer risk. Participants receive their own stem cells that have been genetically corrected with a lentiviral vector to fix the faulty FANCA gene. The study e…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Hope fades: trial of Tay-Sachs drug venglustat terminated early
Disease control Stopped earlyThis Phase 3 trial tested an oral drug called venglustat in 75 adults and children with late-onset Tay-Sachs or Sandhoff disease, rare genetic disorders that cause progressive nerve damage. The drug aimed to lower toxic fat buildup in the brain and slow disease worsening. However…
Phase 3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a scented fan ease breathlessness at the end of life?
Symptom relief Stopped earlyThis study looked at whether blowing a fan with aromatherapy on the face can help reduce breathlessness in people with terminal illness. The trial planned to enroll 26 adults who were near the end of life and had trouble breathing. Participants were randomly assigned to receive a…
Sponsor: Tsai-Wei Huang • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Home infusions may help patients stick to treatment
Knowledge-focused Stopped earlyThis study looks at whether people with Fabry, Gaucher, or Hunter disease are more likely to continue their IV treatment when it's given at home versus at a hospital. Researchers will review existing data from 222 patients in Mexico. No new treatments are given; the goal is to un…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Gene Editing's lasting impact: a 10-Year safety watch
Knowledge-focused Stopped earlyThis study checks on people who previously received gene editing for hemophilia B or mucopolysaccharidosis (MPS) I or II. No new treatment is given; instead, participants are monitored for up to 10 years to see if any new health problems or worsening of existing conditions appear…
Sponsor: Sangamo Therapeutics • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Scientists dive into rare cholesterol disorders to uncover clues
Knowledge-focused Stopped earlyThis study looks at rare genetic disorders where the body can't make cholesterol properly, which can cause birth defects and learning problems. Researchers collect blood, urine, and tissue samples from affected people and their families to learn more about these conditions. The g…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Fabry disease sperm study halted early
Knowledge-focused Stopped earlyThis study aimed to find out how common sperm problems are in men with Fabry disease. Researchers planned to check sperm samples from 22 men aged 18 to 65. The study was stopped early, so results are limited.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Why are people with this rare bone disorder prone to diabetes?
Knowledge-focused Stopped earlyThis pilot study aims to understand why people with pseudohypoparathyroidism type 1A (PHP1A) have a higher risk of type 2 diabetes. Researchers will measure insulin sensitivity and beta-cell function in 14 participants with PHP1A or related conditions, comparing them to matched h…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Superhero training for food allergy safety falls short
Knowledge-focused Stopped earlyThis study aimed to help children aged 6-8 from low-income families learn how to avoid foods they are allergic to. The program used fun, hands-on activities to teach safety skills. The study was stopped early, so we don't have clear results on whether it worked.
Sponsor: Kent State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Rare disease study aims to map MLIV's natural course
Knowledge-focused Stopped earlyThis study followed 7 people with Mucolipidosis Type IV (MLIV) to learn how the disease naturally progresses. Researchers used tests like neuropsychological exams, blood and urine tests, and brain MRIs to find better ways to measure the disease. The goal was to improve future cli…
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC